COMPASS THERAPEUTICS, INC. Long-Term Debt
COMPASS THERAPEUTICS, INC. (CMPX) had Long-Term Debt of $0 as of 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtNoncurrent · last filed 2022-03-18
- 2021-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2021-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2021-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2020-12-31: Long-term Debt, Excluding Current Maturities $1.87M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 |
| 2020-12-31 | $1.87M 10-K · filed 2022-03-18 |
| 2020-09-30 | $3.73M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $5.59M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $9.29M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |